RESUMO
Haemoglobin (Hb) thresholds and red blood cells (RBC) transfusion strategies in traumatic brain injury (TBI) are controversial. Our objective was to assess the association of Hb values with long-term outcomes in critically ill TBI patients. We conducted a secondary analysis of CENTER-TBI, a large multicentre, prospective, observational study of European TBI patients. All patients admitted to the Intensive Care Unit (ICU) with available haemoglobin data on admission and during the first week were included. During the first seven days, daily lowest haemoglobin values were considered either a continous variable or categorised as < 7.5 g/dL, between 7.5-9.5 and > 9.5 g/dL. Anaemia was defined as haemoglobin value < 9.5 g/dL. Transfusion practices were described as "restrictive" or "liberal" based on haemoglobin values before transfusion (e.g. < 7.5 g/dL or 7.5-9.5 g/dL). Our primary outcome was the Glasgow outcome scale extended (GOSE) at six months, defined as being unfavourable when < 5. Of 1590 included, 1231 had haemoglobin values available on admission. A mean Injury Severity Score (ISS) of 33 (SD 16), isolated TBI in 502 (40.7%) and a mean Hb value at ICU admission of 12.6 (SD 2.2) g/dL was observed. 121 (9.8%) patients had Hb < 9.5 g/dL, of whom 15 (1.2%) had Hb < 7.5 g/dL. 292 (18.4%) received at least one RBC transfusion with a median haemoglobin value before transfusion of 8.4 (IQR 7.7-8.5) g/dL. Considerable heterogeneity regarding threshold transfusion was observed among centres. In the multivariable logistic regression analysis, the increase of haemoglobin value was independently associated with the decrease in the occurrence of unfavourable neurological outcomes (OR 0.78; 95% CI 0.70-0.87). Congruous results were observed in patients with the lowest haemoglobin values within the first 7 days < 7.5 g/dL (OR 2.09; 95% CI 1.15-3.81) and those between 7.5 and 9.5 g/dL (OR 1.61; 95% CI 1.07-2.42) compared to haemoglobin values > 9.5 g/dL. Results were consistent when considering mortality at 6 months as an outcome. The increase of hemoglobin value was associated with the decrease of mortality (OR 0.88; 95% CI 0.76-1.00); haemoglobin values less than 7.5 g/dL was associated with an increase of mortality (OR 3.21; 95% CI 1.59-6.49). Anaemia was independently associated with long-term unfavourable neurological outcomes and mortality in critically ill TBI patients.Trial registration: CENTER-TBI is registered at ClinicalTrials.gov, NCT02210221, last update 2022-11-07.
Assuntos
Transfusão de Sangue , Lesões Encefálicas Traumáticas , Estado Terminal , Hemoglobinas , Unidades de Terapia Intensiva , Humanos , Lesões Encefálicas Traumáticas/terapia , Lesões Encefálicas Traumáticas/sangue , Lesões Encefálicas Traumáticas/mortalidade , Lesões Encefálicas Traumáticas/complicações , Masculino , Feminino , Pessoa de Meia-Idade , Hemoglobinas/análise , Estudos Prospectivos , Estado Terminal/terapia , Adulto , Unidades de Terapia Intensiva/organização & administração , Unidades de Terapia Intensiva/estatística & dados numéricos , Transfusão de Sangue/métodos , Transfusão de Sangue/estatística & dados numéricos , Idoso , Anemia/terapia , Anemia/sangue , Resultado do Tratamento , Escala de Resultado de Glasgow , Transfusão de Eritrócitos/métodos , Transfusão de Eritrócitos/estatística & dados numéricosRESUMO
We investigated independent factors predicting neurological outcome and death, comparing in-hospital (IHCA) and out-of-hospital cardiac arrest (OHCA) patients. The study was conducted in the mixed 34-bed Intensive Care Department at the Hôpital Universitaire de Bruxelles (HUB), Belgium. All adult consecutive cardiac arrest (CA) survivors were included between 2004 and 2022. For all patients, demographic data, medical comorbidities, CA baseline characteristics, treatments received during Intensive Care Unit stay, in-hospital major complications, and neurological outcome at three months after CA, using the Cerebral Performance Category (CPC) scale, were collected. In the multivariable analysis, in the IHCA group (n = 540), time to return of spontaneous circulation (ROSC), older age, unwitnessed CA, higher lactate on admission, asystole as initial rhythm, a non-cardiac cause of CA, the occurrence of shock, the occurrence of acute kidney injury (AKI), and the presence of previous neurological disease and of liver cirrhosis were independent predictors of an unfavorable neurological outcome. Among patients with OHCA (n = 567), time to ROSC, older age, higher lactate level on admission, unwitnessed CA, asystole or pulseless electrical activity (PEA) as initial rhythm, the occurrence of shock, a non-cardiac cause of CA, and a previous neurological disease were independent predictors of an unfavorable neurological outcome. To conclude, in our large cohort of mixed IHCA and OHCA patients, we observed numerous factors independently associated with a poor neurological outcome, with minimal differences between the two groups, reflecting the greater vulnerability of hospitalized patients.
RESUMO
Traumatic brain injury (TBI) and subarachnoid hemorrhage (SAH) are critical neurological conditions that necessitate specialized care in the Intensive Care Unit (ICU). Managing cerebral perfusion pressure (CPP) and mean arterial pressure (MAP) is of primary importance in these patients. To maintain targeted MAP and CPP, vasopressors and/or inotropes are commonly used. However, their effects on cerebral oxygenation are not fully understood. The aim of this review is to provide an up-to date review regarding the current uses and pathophysiological issues related to the use of vasopressors and inotropes in TBI and SAH patients. According to our findings, despite achieving similar hemodynamic parameters and CPP, the effects of various vasopressors and inotropes on cerebral oxygenation, local CBF and metabolism are heterogeneous. Therefore, a more accurate understanding of the cerebral activity of these medications is crucial for optimizing patient management in the ICU setting.
RESUMO
Cardiac arrest survivors suffer the repercussions of anoxic brain injury, a critical factor influencing long-term prognosis. This injury is characterised by profound and enduring metabolic impairment. Ketone bodies, an alternative energetic resource in physiological states such as exercise, fasting, and extended starvation, are avidly taken up and used by the brain. Both the ketogenic diet and exogenous ketone supplementation have been associated with neuroprotective effects across a spectrum of conditions. These include refractory epilepsy, neurodegenerative disorders, cognitive impairment, focal cerebral ischemia, and traumatic brain injuries. Beyond this, ketone bodies possess a plethora of attributes that appear to be particularly favourable after cardiac arrest. These encompass anti-inflammatory effects, the attenuation of oxidative stress, the improvement of mitochondrial function, a glucose-sparing effect, and the enhancement of cardiac function. The aim of this manuscript is to appraise pertinent scientific literature on the topic through a narrative review. We aim to encapsulate the existing evidence and underscore the potential therapeutic value of ketone bodies in the context of cardiac arrest to provide a rationale for their use in forthcoming translational research efforts.
Assuntos
Parada Cardíaca , Corpos Cetônicos , Corpos Cetônicos/metabolismo , Humanos , Parada Cardíaca/metabolismo , Animais , Dieta CetogênicaRESUMO
BACKGROUND: Acetazolamide is a non-competitive inhibitor of carbonic anhydrase, an enzyme expressed in different cells of the central nervous system (CNS) and involved in the regulation of cerebral blood flow (CBF). The aim of this review was to understand the effects of acetazolamide on CBF, intracranial pressure (ICP) and brain tissue oxygenation (PbtO2) after an acute brain injury (ABI). METHODS: Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement (PRISMA), we performed a comprehensive, computer-based, literature research on the PubMed platform to identify studies that have reported the effects on CBF, ICP, or PbtO2 of acetazolamide administered either for therapeutic or diagnostic purposes in patients with subarachnoid hemorrhage, intracerebral hemorrhage, traumatic brain injury, and hypoxic-ischemic encephalopathy. RESULTS: From the initial search, 3430 records were identified and, through data selection, 11 of them were included for the qualitative analysis. No data on the effect of acetazolamide on ICP or PbtO2 were found. Cerebral vasomotor reactivity (VMR-i.e., the changing in vascular tone due to a vasoactive substance) to acetazolamide tends to change during the evolution of ABI, with the nadir occurring during the subacute stage. Moreover, VMR reduction was correlated with clinical outcome. CONCLUSIONS: This systematic review showed that the available studies on the effects of acetazolamide on brain hemodynamics in patients with ABI are scarce. Further research is required to better understand the potential role of this drug in ABI patients.
RESUMO
A hipertensão arterial é uma doença de elevada prevalênciana população mundial, sendo fator de risco para doençascardiovasculares. No nosso país, o Programa Nacional deHipertensão Arterial vem evoluindo com altas taxas deabandono às consultas e baixa aderência às medidas geraise medicamentosas. A satisfação dos usuários com a atençãoprestada pelo sistema de saúde é indicador de qualidadedos serviços e poderoso instrumento para melhorar aadesão e reduzir o abandono. Em 2001, foi implementadoum modelo de atendimento alternativo, caracterizado porconsultas por vários profissionais (médico, enfermeiro enutricionista), em rodízio, coexistente ao modelo médicotradicional, em uma unidade básica do Município do Riode Janeiro. Avaliou-se a satisfação dos usuários após um ecinco anos de acompanhamento, através de questionáriopreviamente validado. Após o primeiro ano, não houvediferenças significativas na satisfação em geral com os serviçosprestados em ambos os modelos de atenção (89,6%X 95,9% p=0,1). Após cinco anos, houve maior percentualde pacientes extremamente e/ou bastante satisfeitos noatendimento pelos vários profissionais em relação àquelesatendidos apenas pelos médicos (97,2 X 78% p<0,0001).A satisfação foi melhor também em relação à acessibilidadee à qualidade da consulta. Este fato pode ser atribuído àcriação de maior vínculo dos pacientes com os profissionaisda equipe de saúde após um intervalo de tempo suficientepara que se sentissem seguros em relação ao atendimentona Instituição, garantindo respostas mais livres e reais.
Arterial Hypertension, which is a highly prevalent conditionaround the world, increases the risk of cardiovasculardiseases. The Brazilian National Program of Hypertensionhas experimented high drop-out rates and low rates ofcompliance with general and drug therapies. Customers`satisfaction with the care provided by the health system isan indicator of the quality of the services rendered and apowerful instrument to improve compliance and reducedrop-out. In 2001, an alternative model of care, characterizedby consultation with several professionals in rotation(physician, nurse and nutritionist), was implemented tocoexist with a traditional model, in a primary care unit ofthe municipality of Rio de Janeiro, Southeastern Brazil.Customers` satisfaction after 1-year and 5-year follow-upwas assessed with a previously validated questionnaire.After the first year, no significant difference in customers`satisfaction with the services rendered by both models wasnoted (89.6% X 95.9%; p=0.1). After five years, there wasa higher rate of extremely and/or very satisfied customersamong those cared for by several professionals, comparedwith those cared for by physicians only (97.2% X 78%;p<0.0001). Satisfaction was also greater as for access to theservices and the quality of the consultations. This fact maybe accounted for by closer links with the health team after aperiod long enough to foster a feeling of safety with the carereceived, thus leading to freer and more realistic answers.